舒利迭吸入治疗老年重度阻塞性肺疾病的临床分析  

Clinical analysis of salmeterol fluticasone propionate aerosol inhalation treatment of senile severe obstructive pulmonary disease

作　　者：石芳[1] 李洪全[1] 

机构地区：[1]新疆生产建设兵团第六师医院老年干部科,新疆五家渠831300

出　　处：《中国医药科学》2015年第19期106-108,共3页China Medicine And Pharmacy

摘　　要：目的研究评价舒利迭吸入治疗老年重度慢性阻塞性肺疾病对患者血气及肺功能的影响。方法回顾性分析80例在我院确诊并接受治疗的老年重度慢性阻塞性肺疾病患者,根据患者的治疗方式分为对照、实验两组,每组40例,两组均贯彻实施吸氧、解痉、平喘、抗感染等常规治疗,实验组在此基础上加用舒利迭吸入治疗,研究过程中对两组治疗有效率,及治疗前后血气、肺功能指标变化的差异施以比较,并用统计学处理。结果实验组治疗总有效率为92.5%,对照组的治疗总有效率为72.5%,两者相比可见实验组治疗效果明显优于对照组,差异有统计学意义(P<0.05);两组治疗前血气、肺功能指标比较无统计学意义(P>0.05),两组治疗后各指标同组比较均明显改善(P<0.05),但相比之下实验组的改善幅度显著优于对照组(P<0.05)。结论采用舒利迭吸入治疗老年重度慢性阻塞性肺疾病疗效肯定,明显缓解临床症状,且能有效改善患者血气与肺功能指标,是治疗本病的一种有效方案,适合在临床推广应用。Objective To study the effect of blood gas and pulmonary function of salmeterol fluticasone propionate aerosol inhalation treatment of senile severe obstructive pulmonary disease. Methods Retrospectively analyzed 80 patients with senile severe obstructive pulmonary disease, who were diagnosed and were received treatment in our hospital, were divided into control group and experimental group according to the patients＇ treatments, with 40 cases in each group. To carry out and implement the routine treatment of oxygen inhalation, spasmolysis, antiasthmatic, and anti-infection and so on in the two groups, and based on which, the experimental group was treated with salmeterol fluticasone propionate aerosol inhalation. To compare the differences of the treatment effective rate, the index changes of blood gas and pulmonary function of pre and post treatment between the two groups during the course of studying, and to make statistical treatment. Results The treatment total effective rate in experimental group（92.5%） was obviously better than which in control group（72.5%）, the differences was statically significant（P〈0.05）. The differences of blood gas and pulmonary function of the two groups before treatment was no statistical significance（P〉0.05）, while which after treatment had obviously improved（P〈0.05）, but the improved amplitude in experimental group was obviously better than which in control group（P〈0.05）. Conclusion Salmeterol fluticasone propionate aerosol inhalation treatment of senile severe obstructive pulmonary disease has definite therapeutic effect, could obviously relieve the clinical symptoms, and could effectively improve the blood gas and pulmonary function index, is a feasible scheme, is fit to clinical popularization and application.

关 键 词：舒利迭 老年重度慢性阻塞性肺疾病 血气指标 肺功能 

分 类 号：R563.9[医药卫生—呼吸系统]